-
Innovation Ranking
NewInnovation Ranking – RPC Inc
RPC Inc (RPC) is an oil and gas company that provides specialized oilfield services and equipment to independent and major oilfield companies. It also carries out the exploration, production and development of oil and gas properties in the US's southwest, mid-continent, Gulf of Mexico, Rocky Mountain and Appalachian regions. The company’s business units include cudd pressure control, Patterson services and thru tubing solutions. Its major services include downhole tools, pressure pumping, snubbing, coiled tubing, wireline, nitrogen, well control and fishing....
-
Company Insights
Innovation and Patenting activity of RPC Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of RPC Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ozanimod Hydrochloride in Crohn’s Disease (Regional Enteritis)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ozanimod Hydrochloride in Crohn's Disease (Regional Enteritis) Drug Details: Ozanimod hydrochloride (Zeposia) is an immunomodulatory...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cendakimab in Eosinophilic Esophagitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cendakimab in Eosinophilic Esophagitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cendakimab in Eosinophilic Esophagitis Drug Details: cendakimab (RPC-4046, CC-93538) is under development...
-
Company Profile
RPC Inc – Company Profile
RPC Inc (RPC) is an oil and gas company that provides specialized oilfield services and equipment to independent and major oilfield companies. It also carries out the exploration, production and development of oil and gas properties in the US's southwest, mid-continent, Gulf of Mexico, Rocky Mountain and Appalachian regions. The company’s business units include cudd pressure control, Patterson services and thru tubing solutions. Its major services include downhole tools, pressure pumping, snubbing, coiled tubing, wireline, nitrogen, well control and fishing....
Add to Basket -
Company Profile
Brambles Ltd – Company Profile
Brambles Ltd (Brambles) is a supply chain and logistics company. It carries out transportation of goods in a sustainable manner through its reuse business model. The company manages, maintains, transports, and supplies high-quality pallets, containers, reusable/returnable plastic/produce container/crate (RPC), bins, trays, and store displays to its customers under CHEP brand. Brambles provides supply chain solutions to various industries including consumer goods, liquid and dry applications, automotive and industrial sector, and retail sectors. The company has presence in countries across Europe,...
Add to Basket -
Product Insights
Net Present Value Model: Cendakimab
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Cendakimab Drug Details cendakimab (RPC-4046, CC-93538)...
-
Product Insights
Net Present Value Model: Zeposia
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Zeposia Drug Details Ozanimod hydrochloride (Zeposia)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – cendakimab
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry cendakimab Drug Details cendakimab (RPC-4046, CC-93538) is under development for the treatment of eosinophilic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ozanimod hydrochloride
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ozanimod hydrochloride Drug Details Ozanimod hydrochloride (Zeposia) is an immunomodulatory agent. It is formulated...